Type
Business expansion
Country
Ireland
Region
Southern and Eastern; Dublin;
Location of affected unit(s)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

350 jobs
Number of planned job creations
Job creation
Announcement Date
13 February 2018
Employment effect (start)
13 February 2018
Foreseen end date
31 December 2021

Description

Medical product manufacturer MSD is to create 350 new jobs in Dublin.

The jobs wil be based at the company's facility in North Dublin, which had closed in 2013, with the loss of 570 jobs.

The new positions are in quality, engineering, manufacturing and biochemistry. The products that will be manufactured at the Dublin plant will be biological medicines, particularly in the area of immuno-oncology.

MSD currently employs 1700 across Ireland, having increased its workforce in Ireland by 330 last year. 


Sources

  • 13 February 2018: RTE
  • 13 February 2018: Silicon Republic.com

Citation

Eurofound (2018), MSD, Business expansion in Ireland, factsheet number 93254, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/93254.